We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock
GRNA

Delisted

GRNA was delisted on the 21st of July, 2023.

Back to rankings

57 hedge funds and large institutions have $86.2M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

520% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 5

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

32% more capital invested

Capital invested by funds: $65.2M → $86.2M (+$21M)

14% more funds holding

Funds holding: 50 → 57 (+7)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
57
Holders Change
+7
Holders Change %
+14%
% of All Funds
0.98%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
17
Increased
31
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$8.64M
2
Baird Financial Group
Baird Financial Group
Wisconsin
+$7.48M
3
BlackRock
BlackRock
New York
+$5.91M
4
CGC
Continental Grain Company
New York
+$4.01M
5
BNP Paribas Asset Management
BNP Paribas Asset Management
France
+$2.55M

Top Sellers

Rank Fund Capital Flow
1
VS
VK Services
California
-$11.5M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$2.32M
3
Squarepoint
Squarepoint
New York
-$181K
4
HF
HRT Financial
New York
-$157K
5
Two Sigma Investments
Two Sigma Investments
New York
-$68K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
51
UBS Group
Switzerland
$7K +$1.02K +389 +16%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$7K +$7.86K +3,001 +3,847%
Wells Fargo
53
Wells Fargo
California
$3K +$1.6K +613 +87%
National Bank of Canada
54
National Bank of Canada
Quebec, Canada
$2K – – –
PA
55
Parallel Advisors
California
$1K +$908 +347 New
Fidelity Investments
56
Fidelity Investments
Massachusetts
$1K +$935 +357 New
Bank of Montreal
57
Bank of Montreal
Ontario, Canada
$39 +$42.5K +16,244 New
VS
58
VK Services
California
– -$11.5M -5,221,454 Closed
Squarepoint
59
Squarepoint
New York
– -$181K -81,699 Closed
HF
60
HRT Financial
New York
– -$157K -71,114 Closed
Two Sigma Investments
61
Two Sigma Investments
New York
– -$68K -30,871 Closed
EGM
62
Engineers Gate Manager
New York
– -$38K -16,980 Closed
JF
63
Jump Financial
Illinois
– -$28K -12,800 Closed
State of Wisconsin Investment Board
64
State of Wisconsin Investment Board
Wisconsin
– -$26K -11,852 Closed
Victory Capital Management
65
Victory Capital Management
Texas
– -$23K -10,386 Closed
PCM
66
Penserra Capital Management
California
– -$7K -3,614 Closed
CAPTRUST Financial Advisors
67
CAPTRUST Financial Advisors
North Carolina
– -$2K -817 Closed
1 2
3

GRNA Hedge Fund Activity: Q3 2022 in Review

57 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q3 2022, worth a combined $86.2M — up 32% from $65.2M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new GRNA positions and 10 closed out — a net gain of 7 holders — while 31 added to existing stakes and 5 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $8.64M. The largest seller was VK Services, exiting entirely with an estimated $11.5M sold.

  • 57 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q3 2022, up from 50 in Q2 2022.
  • Funds reported $86.2M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q3 2022, up 32% quarter-over-quarter.
  • 17 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q3 2022 and 10 closed out, a net change of +7 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q3 2022 was Cormorant Asset Management, an estimated $8.64M added.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q3 2022 was VK Services, an estimated $11.5M sold.

Based on aggregated 13F filings for Q3 2022.